Abstract: Aspects of the invention relate to compounds, pharmaceutical compositions, methods for the manufacturing of compounds and methods for treatment of various disorders mediated at least in part by one or more galectins.
Type:
Grant
Filed:
August 3, 2018
Date of Patent:
February 21, 2023
Assignee:
GALECTIN SCIENCES, LLC
Inventors:
Raphael Nir, Eliezer Zomer, Peter G. Traber, Joseph M. Johnson, Ryan George, Sharon Shechter